Social and other specific services – public contracts
Legal Basis:
Directive 2014/24/EU
Section I: Contracting authority
I.1)Name and addressesOfficial name: Region Skåne, Koncernstab inköp och ekonomistyrning
National registration number: 232100-0255
Town: KRISTIANSTAD
NUTS code:
SE224 Skåne länPostal code: 29189
Country: Sweden
Contact person: Ulf Rosqvist
E-mail:
Ulf.Rosqvist@skane.seInternet address(es): Main address:
http://www.skane.se I.1)Name and addressesOfficial name: Vestre Viken Hospital Trust
National registration number: 894 166 762
Town: Drammen
NUTS code:
NO08 Oslo og VikenCountry: Norway
Contact person: Kristine Sahlberg
E-mail:
suppliers@carematrix.euInternet address(es): Main address:
http://www.vestreviken.no I.2)Information about joint procurementThe contract involves joint procurement
In the case of joint procurement involving different countries, state applicable national procurement law:
I.3)CommunicationAdditional information can be obtained from the abovementioned address
I.4)Type of the contracting authorityRegional or local authority
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
Carematrix Pre-Commercial Procurement (PCP)
Reference number: 2022-O002487
II.1.2)Main CPV code73100000 Research and experimental development services
II.1.3)Type of contractServices
II.1.4)Short description:
This contract notice invites interested operators to submit tenders to a procurement.
The procurement aims to trigger new solutions to be developed and tested to address the following challenge: To anticipate and address the needs of people suffering from multimorbititiy, by ensuring timely service access, co-managed care journeys and transitions between specialties and sectors. It will address the white spaces between silo-based single-diagnosis treatment tracks, and the white spaces occurring in caregiver transitions. Some of the main technical challenges to be addressed are: 20 % reduction in time spent for visits to care facilities and increased patient safety by 50 % fewer inter-organisational patient data-related incidents.
This PCP procurement is a joint procurement by different procurers across Europe that are all facing the same common challenge and are thus looking for similar solutions (so-called ‘buyers group’).
II.1.5)Estimated total valueValue excluding VAT: 3 360 000.00 EUR
II.1.6)Information about lotsThis contract is divided into lots: no
II.2)Description
II.2.3)Place of performanceNUTS code: SE224 Skåne län
Main site or place of performance:
Main site or place of performance:
Testing is expected to take place at the procurers' sites: Basque country(ES), Oslo-Viken (NO) and Skåne (SE).
II.2.4)Description of the procurement:
The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to a number of R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions.
Each selected operator will be awarded a framework agreement that covers 3 R&D phases.
The 3 phases are:
-R&D up to solution design
-R&D up to a prototype
-R&D up to original development, validation and testing of a limited set of first products or services.
After each phase, intermediate evaluations will be carried out to progressively select the best of the competingsolutions. The contractors with the best-value-for-money solutions will be offered a specific contract for the nextphase.
Testing is expected to take place in Basque country(ES), Oslo-Viken (NO) and Skåne (SE). This testing mayalso serve as a first customer test reference for the contractors. The procurement is expected to start inmarch-23 and end in september-25.
The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate duringthe PCP and will be able to use them to exploit the full market potential of the developed solutions i.e. beyondthe procurers. The market potential is estimated at EUR 75 000 000 000 (across Europe).
Award criteria:
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)Estimated valueValue excluding VAT: 3 360 000.00 EUR
II.2.7)Duration of the contract or the framework agreementStart: 13/03/2023
End: 26/09/2025
II.2.13)Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: yes
Identification of the project:
The procurement is related to a project and/or programme financed by European Union funds:
Agreement No 964370 — Carematrix PCP (see carematrix.eu)
II.2.14)Additional information
This procurement receives funding from the European Union’s Horizon 2020 Research and Innovation Programme, under grant agreement No 964370 — Carematrix PCP (see carematrix.eu). The EU has given a grant for this procurement, but is not participating as a contracting authority in the procurement.
Section III: Legal, economic, financial and technical information
III.1)Conditions for participation
III.1.4)Objective rules and criteria for participationList and brief description of rules and criteria:
Selection criteria as stated in the procurement documents
III.2)Conditions related to the contract
III.2.3)Information about staff responsible for the performance of the contractObligation to indicate the names and professional qualifications of the staff assigned to performing the contract
Section IV: Procedure
IV.1)Description
IV.1.1)Form of procedureOpen procedure
IV.1.3)Information about framework agreementThe procurement involves the establishment of a framework agreement
In the case of framework agreements, provide justification for any duration exceeding 4 years:
The procurement involves the establishment of a framework agreement
Framework agreement with several operators In the case of framework agreements, provide justification for any duration exceeding 4 years: Carematrix PCP expect to award a minimum of 8 framework agreements.
IV.1.10)Identification of the national rules applicable to the procedure:
IV.1.11)Main features of the award procedure:
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure IV.2.2)Time limit for receipt of tenders or requests to participate / Time limit for receipt of expressions of interestDate: 10/01/2023
Local time: 23:59
IV.2.4)Languages in which tenders or requests to participate may be submitted:English
Section VI: Complementary information
VI.2)Information about electronic workflowsElectronic invoicing will be accepted
VI.3)Additional information:
This procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. This is because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs.
Publication of this contract notice in the EU Official Journal is not to be understood as a waiver of this exemption. Publication is made on a voluntary basis and the procurement will not follow the procedures under the EU public procurement directives, but rather the procedure described in the tender documentation.
More information:
See:
- the project website (carematrix.eu)
- the open market consultation material (https://carematrix.eu/open-market-consultation/)
Participation in the open market consultation (OMC) that was held as part of the preparation for this procurement is not a prerequisite for submitting a tender. All material and recordings from the OMC are publicly available at carematrix.eu
Mercell notice: https://opic.com/id/afefkbztfe
VI.4)Procedures for review
VI.4.1)Review bodyOfficial name: Förvaltningsrätten
Town: Malmö
Country: Sweden
VI.5)Date of dispatch of this notice:01/11/2022